Copertina

Towards the Use of Metabolic Volatiles in Breath for Determining Drug Response: Gstachamine as an Unlabeled Substrate to Measure CYP3A4 Activity

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Valentina Stock, Rebecca Hofer, Klaus R. Liedl, Jakob Troppmair, Thierry Langer, Hubert Gstach, Christian Dank, Sarah Kammerer, Veronika Ruzsanyi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Structural Impact of 4‐Hydroxynonenal Modification on Human Cytochrome CYP4F11
di: Olena Gnatyuk, et al.
Pubblicazione: (2026)

Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
di: Jingjing Zhang, et al.
Pubblicazione: (2024)

Fluoromethylketone‐Fragment Conjugates Designed as Covalent Modifiers of Ec DsbA are Atypical Substrates
di: Bradley C. Doak, et al.
Pubblicazione: (2024)

Biosynthesis of Natural and Unnatural Perylenequinones for Drug Development
di: Zengping Su, et al.
Pubblicazione: (2024)

Accelerating Drug Discovery through Knowledge Sharing
di: Rory C. McAtee
Pubblicazione: (2026)

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions through Advanced Techniques
di: Lidia E. Chiñas‐Rojas, et al.
Pubblicazione: (2024)

Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
di: Gints Kalnins, et al.
Pubblicazione: (2024)

Recent Progress on Topical Drug Therapy for Corneal Neovascularization
di: Xin‐Can Huang, et al.
Pubblicazione: (2025)

Out of the Dark, into the Light: Metabolic Fluorescent Labeling of Nucleic Acids
di: J. Iven H. Knaack, et al.
Pubblicazione: (2024)

Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance
di: Linjia Su, et al.
Pubblicazione: (2024)

Current Approaches and Strategies Applied in First‐in‐class Drug Discovery
di: Idrees Mohammed, et al.
Pubblicazione: (2024)

Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
di: Yaxin Lei, et al.
Pubblicazione: (2025)

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
di: Jinmin Miao, et al.
Pubblicazione: (2024)

Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
di: Sadık Hüseyin Cemali, et al.
Pubblicazione: (2025)

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites
di: Anne Robert, et al.
Pubblicazione: (2025)

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape
di: Pengwen Chen, et al.
Pubblicazione: (2024)

The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design
di: Konstantina Nikovia, et al.
Pubblicazione: (2026)

Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
di: Ariane F. Hübner, et al.
Pubblicazione: (2026)

Drug Discovery Summit: 14 th Swiss Course on Medicinal Chemistry
di: Céline Schuppisser, et al.
Pubblicazione: (2024)

Benzamide Derivatives of Thioacridine as DYRK2 and DYRK3 Dual Inhibitors
di: Jean Roussel, et al.
Pubblicazione: (2025)

Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐Trypanosoma cruzi Activity for Chagas Disease
di: Rocío Marisol Espinoza‐Chávez, et al.
Pubblicazione: (2024)

Nonsteroidal Anti‐Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies
di: Paola Laghetti, et al.
Pubblicazione: (2025)

Design, Synthesis, and Biological Evaluation of Evodiamine Derivatives as Antibody–Drug Conjugate Payloads
di: Ruifeng Liu, et al.
Pubblicazione: (2025)

A New Paradigm for Drug Deuteration Based on Computed Binding Isotope Effects
di: Agata Paneth, et al.
Pubblicazione: (2025)

Imidazole‐Based Liposomes: Emerging pH‐Sensitive Drug Delivery Tools
di: Faeze Shojaeinia, et al.
Pubblicazione: (2025)

Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination”
di: Nancy Cham, et al.
Pubblicazione: (2025)

Fluorescence‐Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines
di: Jan Voldřich, et al.
Pubblicazione: (2024)

Structure and Dynamics of Monoclonal Antibody Domains Using Spins, Scattering, and Simulations
di: Veronika A. Szalai, et al.
Pubblicazione: (2025)

A Novel Tertiary Carbamate Prodrug Strategy to Overcome Metabolic Barriers in Oral Ketamine Delivery
di: Juulia Järvinen, et al.
Pubblicazione: (2026)

Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light‐Induced PPARα Activation
di: Minh Sai, et al.
Pubblicazione: (2024)

Exploiting Pharmacokinetic/Pharmacodynamic Methods for Optimizing and Accelerating Drug Development of Innovative Anti‐Infectives
di: Katharina Rox
Pubblicazione: (2026)

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
di: Tim Kirkman, et al.
Pubblicazione: (2024)

Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes
di: Caitlin L. Gare, et al.
Pubblicazione: (2024)

Estimation of In Vivo Half‐Life From In Vitro Metabolic Clearance, Protein, and Cell Membrane Affinity Assays
di: Carla Pou Miralbell, et al.
Pubblicazione: (2025)

Structure–Property Associations: Breaking Paradigms for Linking Chemical Structures and Biological Properties in Drug Discovery
di: Edgar López‐López, et al.
Pubblicazione: (2025)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
di: Jochem Nelen, et al.
Pubblicazione: (2026)

AZP2006 (Ezeprogind®): a Promising New Drug Candidate in the Battle Against Neurodegenerative Diseases
di: Philippe Verwaerde, et al.
Pubblicazione: (2025)

Multidisciplinary Preclinical Investigations on Ferrocenyl, Ruthenocenyl, and Benzyl Derivatives of Niridazole as New Drug Candidates against Schistosomiasis
di: Tanja Karpstein, et al.
Pubblicazione: (2025)

Targeting Tetraspanins at Cell Interfaces: Functional Modulation and Exosome‐Based Drug Delivery for Precise Disease Treatment
di: Kun Xu, et al.
Pubblicazione: (2024)

Sertraline as a Scaffold for Antitrypanosoma Cruzi Drug Development: Design of Novel Derivatives and Computational Target Screening
di: Ali S. Mijoba, et al.
Pubblicazione: (2025)